TP53 and cancer: Since mutant p53 mediates interactions between mesothelial and cancer cells during metastasis46, ACP6 downregulation followed by increased LPA signaling may also regulate bidirectional communication between cancer cells and other components of the HGSOC microenvironment such as immune cells, cancer-associated fibroblasts, adipocytes, or endothelial cells.